In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies

References

• Tam KY, Leung KC, Wang YX. Chemoembolization agents for cancer treatment. Eur J Pharm Sci. 2011;44:1–10.
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Maestri M, Gavini E, et al. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opin Drug Deliv. 2013;10:679–690.
   PubMed Web of Science ®Google Scholar
• Breedos C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30:969–977.
   PubMed Web of Science ®Google Scholar
• Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24:1395–1403.
   PubMed Web of Science ®Google Scholar
• Bilhim T, Pisco JM. The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of the post-embolization symptoms after uterine artery embolization. Pharmaceuticals. 2010;3:1729–1738.
   Google Scholar
• Pisco JM, Bilhim T, Duarte M, et al. Pelvic pain after uterine artery embolization: a prospective randomized study of polyvinyl alcohol particles mixed with ketoprofen versus bland polyvinyl alcohol particles. J Vasc Interv Radiol. 2008;19:1537–1542.
   PubMed Web of Science ®Google Scholar
• Salis A, Rassu G, Budai-Szűcs M, et al. Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: A preliminary study. Expert Opin Drug Deliv. 2015;12:1583–1596.
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Maestri M, Gavini E, et al. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 2. Expert Opin Drug Deliv. 2013;10:799–810.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Gonzalez MV, Lloyd AW, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17:335–342.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Holden RR, Bead Embolic DC. Drug-eluting bead: clinical application in the locoregional treatment of tumours. Expert Opin Drug Deliv. 2011;8:153–169.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Adams C, Busby W, et al. Comparative In-vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med. 2006;17:1193–1204.
   PubMed Web of Science ®Google Scholar
• Jain RA, Rhodes CT, Railkar AM, et al. Controlled release of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. J Microencapsul. 2000;17:343–362.
   PubMed Web of Science ®Google Scholar
• Jain RA, Rhodes CT, Railkar AM, et al. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm. 2000;50:257–262.
   PubMed Web of Science ®Google Scholar
• Kranz H, Ylmaz E, Brazeau G,A, et al. In Vitro and In Vivo drug release from a novel in situ forming drug delivery system. Pharmaceut Res. 2007;25:1347–1354.
   Web of Science ®Google Scholar
• Dudeck O, Jordan O, Hoffmann K, et al. Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile. Ajnr. 2006;27:1900–1906.
   PubMed Web of Science ®Google Scholar
• Luan X, Bodmeier R. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters. Eur J Pharm Sci. 2006;27:143–149.
   PubMed Web of Science ®Google Scholar
• Kranz H, Bodmeier R. A biodegradable in situ forming system for controlled drug release. Pharm Sci Suppl. 1998;1:414.
   Google Scholar
• Yapar EA, Inal O, Ozcan Y, et al. Injectable in situ forming microparticles: a novel drug delivery system. Trop J Pharm Res. 2012;11:307–318.
   Web of Science ®Google Scholar
• Woodroof MA, Hutmacher DW. The return of a forgotten polymer—polycaprolactonein the 21st century. Prog Polym Sci. 2010;35:1217–1256.
   Web of Science ®Google Scholar
• Esbensen KH, Guyot D, Westad F, et al. Multivariate data analysis - in practice: an introduction to multivariate data analysis and experimental design. Esbjerg: CAMO Software, Aalborg University; 2002.
   Google Scholar
• Stassen S, Nihant N, Martin V, et al. Microencapsulation by coacervation of poly(lactide-co-glycolide): physicochemical characteristics of the phase separation process. Polymer. 1994;35:777–785.
   Web of Science ®Google Scholar
• Ruiz JM, Tissier B, Benoit JP. Microencapsulation of peptide: a study of the phase separation of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil. Int J Pharm. 1989;49:69–71.
   Web of Science ®Google Scholar
• Eriksson L, Johansson E, Wikström C. Mixture design—design generation, PLS analysis, and model usage. Chemometr Intel Lab. 1998;43:1–24.
   Web of Science ®Google Scholar
• Rossmann M, Braeuer A, Schluecker E. Supercritical antisolvent micronization of PVP and ibuprofen sodium towards tailored solid dispersions. J Supercrit Fluid. 2014;89:16–27.
   Web of Science ®Google Scholar
• Natarajan V, Krithica N, Madhan B, et al. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. J. Pharm Sci. 2011;100:195–205.
   PubMed Web of Science ®Google Scholar
• Saw CLL, Olivo M, Chin WWL, et al. Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. J Photoch Photobio B. 2007;86:207–218.
   PubMed Web of Science ®Google Scholar
• Trapani A, Laquintana V, Lopedota A, et al. Evaluation of new propofol aqueous solutions for intravenous anesthesia. Int J Pharm. 2004;27:91–98.
   Google Scholar
• Spiegel AJ, Noseworthy MM. Use of nonaqueous solvents in parenteral products. J Pharm Sci. 1963;52:917–927.
   PubMed Web of Science ®Google Scholar
• Okada H, Kamei S, Yoshioka T Takeda Chemical Industries, Ltd., assignee. United States Patent US 5,202,352. 1993 Apr 13.
   Google Scholar
• Dong W, Bodmeier R. Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method. Int J Pharm. 2006;326:128–138.
   PubMed Web of Science ®Google Scholar
• Weiss G, Knoch A, Laicher A, et al. Microencapsulation of ibuprofen by a coacervation process using Eudragit L100–55 as an enteric polymer. Drug Dev Ind Pharm. 1993;19:2751–2764.
   Web of Science ®Google Scholar
• Wu JJ, Chao M, Zhang GQ, et al. Pulmonary and cerebral lipiodol embolism after transcatheter arterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol. 2009;15:633–635.
   PubMed Web of Science ®Google Scholar
• Jani GK, Gohel MC. Effects of selected formulation parameters on the entrapment of diclofenac sodium in ethyl cellulose microspheres. J. Control Release. 1997;43:245–250.
   Web of Science ®Google Scholar
• Giunchedi P, Juliano C, Gavini E, et al. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm. 2002;53:233–239.
   PubMed Web of Science ®Google Scholar
• Murdande SB, Pikal MJ, Shanker RM, et al. Aqueous solubility of crystalline and amorphous drugs: challenges in measurement. Pharm Dev Technol. 2011;16:187–200.
   PubMed Web of Science ®Google Scholar
• Wang YM, Sato H, Adachi I, et al. Optimization of the formulation design of chitosan microspheres containing cisplatin. J. Pharma Sci. 1996;85:1204–1210.
   PubMed Web of Science ®Google Scholar
• Borovac T, Pelage JP, Kasselouri A, et al. Release of ibuprofen from beads for embolization: in vitro and in vivo studies. J Control Release. 2006;115:266–274.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Dreher MR. Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy. J Control Release. 2012;161:338–350.
   PubMed Web of Science ®Google Scholar
• Blümmel J, Reinhardt S, Schäfer M, et al. Drug-eluting beads in the treatment of hepatocellular carcinoma and colorectal cancer metastases to the liver. Eur Oncol Haematol. 2012;3:162–166.
   Google Scholar
• Wáng YXJ, De Baere T, Idée JM, et al. Transcatheter embolization therapy in liver cancer: an update of clinical evidences. Chin J Cancer Res. 2015;27:96–121.
   PubMed Web of Science ®Google Scholar
• Kettenbach J, Stadler A, Katzler IV, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Inter Rad. 2008;31:468–476.
   PubMed Web of Science ®Google Scholar
• Bastian P, Bartkowski R, Köhler H, et al. Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. Eur J Pharm Biopharm. 1998;46:243–254.
   PubMed Web of Science ®Google Scholar
• Brown KT. Fatal pulmonary complications after arterial embolization with 40–120-μm tris-acryl gelatin microspheres. J Vasc Inter Radiol. 2004;15:197–200.
   PubMed Web of Science ®Google Scholar
• Miyayama S, Yamashiro M, Okuda M, et al. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Inter Rad. 2010;33:1168–1179.
   PubMed Web of Science ®Google Scholar
• Laurent A, Beaujeux R, Wassef M, et al. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. Am J Neuroradiol. 1996;17:533–540.
   PubMed Web of Science ®Google Scholar
• Anand A, Pundir R, Pandian CS, et al. Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis. Indian J Pharm Sci. 2009;71:377–381.
   PubMed Web of Science ®Google Scholar
• Kwon SK, Song JJ, Cho CG, et al. Polycaprolactone spheres and theromosensitive Pluronic F127 hydrogel for vocal fold augmentation: in vivo animal study for the treatment of unilateral vocal fold palsy. Laryngoscope. 2013;123:1694–1703.
   PubMed Web of Science ®Google Scholar
• Sanghvi R, Narazaki R, Machatha SG, et al. Solubility improvement of drugs using N-methyl pyrrolidone. AAPS Pharmscitech. 2008;9:366–376.
   PubMed Web of Science ®Google Scholar
• Tucker HLM, Parsons CLM, Ellis S, et al. Tamoxifen impairs prepubertal mammary development and alters expression of estrogen receptor α (ESR1) and progesterone receptors (PGR). Domest Anim Endocrin. 2016;54:95–105.
   PubMed Web of Science ®Google Scholar